You are here

Industry News

Advamed Smart Brief

April 21, 2017
A merger has been announced between Sandhill Scientific and Medovations, both owned by Diversatek, through which they will op -More
April 21, 2017
A mixed shelf offering involving nine unnamed investors has brought in $8.2 million for Novi, Mich.-based Delphinus Medical T -More
April 21, 2017
Tissue Regeneration System's 3D technology has been acquired by Johnson & Johnson unit DePuy Synthes in a move that is expect -More
April 21, 2017
TypeZero Technologies has signed a nonexclusive agreement giving Cellnovo a commercial license to integrate its artificial pa -More
April 21, 2017
A GlobalData report predicts the European market for pancreatic and biliary stents will reach about $84 million by 2023 with  -More
April 21, 2017
The STRIVE trial, a longitudinal, prospective, observational study, has been launched by Illumina spinout Grail in hopes of d -More
April 21, 2017
Cardiac Insight has obtained clearance from the FDA for its single-use, leadless, wearable electrocardiogram sensor, Cardeo S -More
April 21, 2017
The FDA has granted Halyard Health clearance to market its Coolief cooled radiofrequency thermal treatment for relieving chro -More
April 21, 2017
The FDA has given Illinois-based Life Spine clearance to market its Plateau-C Ti cervical spacer system, which comes with OSS -More
April 21, 2017
A recall initiated by Medtronic involving nearly 2,000 StrataMR adjustable valves and shunts has been classified by the FDA a -More

Industry News

RealClear Health
Often undiagnosed, an estimated two to six million people in the United States have a serious heart condition called atrial fibrillation, or AFib. As those living with the disease know, complications from the irregular heartbeat caused by the AFib can be potentially devastating: The average person with AFib is five times more likely to suffer a stroke than someone with a regular heartbeat. Fortunately, there is innovative medical technology available today poised to make a real difference in...
Legal Backgrounder
When a doctor implants a medical device, he or she often requests the presence of a representative of the device manufacturer (a “rep”) in the operating room. Some observers are critical of this practice, demanding thatreps be barred from the O.R. At the same time,some lawyersthink repsin the O.R.should be subject to liability in the court system. This Legal Backgrounder explains why reps often play an important, if limited, role in the O.R., and why that role should not expose reps to lawsuits
Business Wire
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes. The round was led by Philips and UPMC, through its innovation and commercialization arm UPMC Enterprises, with other new and existing investors participating. The funding will support a planned US-based pivotal trial for...
Washington Examiner
Imagine for a moment that you are one of the approximately 44 million women in the U.S. affected by cardiovascular disease, or one of the 24 million with osteoarthritis. You'd want access to the most advanced and effective care. Oftentimes, your doctor would recommend a medical technology or device as an essential component of your treatment – placing a stent in a blocked artery or replacing your knee or hip with a new artificial one, for example. ​​​​​​
Fox Business
Mar. 09, 2017 - AdvaMed CEO Scott Whitaker discusses the impact of the medical device tax on business.​​​​​​